Would like to see Lexaria branch out and secure some U.S. business acquisition(s) instead of relying on the all or nothing aspect of Health Canada's federal licence approval. Being a U.S. based corporation this would be a seamless transaction for them.
I feel they are potentially missing some luctrative transactions that are becoming available at this stage of first mover advantage. Why wait till Nevada joins the frey, by than it could be a diluted market in terms of share prices in the industry.
I have admired this company and it's potential from afar. Finally took the plunge for 20t. The HC issue is what kept me in refrain mode till now. Should they branch out into the U.S. i will be all over the bid for alot more, but for now that's all i wish to risk.
I am sure most investors are thinking along the same lines. Someone needs to get the message out to the management of this company, first mover advantage only comes along for so long, you have to take advantage of it while your share structure is still as good as it is here. GLA
Market Data 
Markets 
AI
